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Essential role of accessory subunit LYRM6 in the
mechanism of mitochondrial complex I
Etienne Galemou Yoga1,2, Kristian Parey1,2,3,7, Amina Djurabekova4,8, Outi Haapanen 4,8, Karin Siegmund1,2,
Klaus Zwicker 5, Vivek Sharma 4,6✉, Volker Zickermann 1,2 & Heike Angerer 1,2✉
Respiratory complex I catalyzes electron transfer from NADH to ubiquinone (Q) coupled to
vectorial proton translocation across the inner mitochondrial membrane. Despite recent
progress in structure determination of this very large membrane protein complex, the cou-
pling mechanism is a matter of ongoing debate and the function of accessory subunits
surrounding the canonical core subunits is essentially unknown. Concerted rearrangements
within a cluster of conserved loops of central subunits NDUFS2 (β1-β2S2 loop), ND1 (TMH5-
6ND1 loop) and ND3 (TMH1-2ND3 loop) were suggested to be critical for its proton pumping
mechanism. Here, we show that stabilization of the TMH1-2ND3 loop by accessory subunit
LYRM6 (NDUFA6) is pivotal for energy conversion by mitochondrial complex I. We deter-
mined the high-resolution structure of inactive mutant F89ALYRM6 of eukaryotic complex I
from the yeast Yarrowia lipolytica and found long-range structural changes affecting the entire
loop cluster. In atomistic molecular dynamics simulations of the mutant, we observed con-
formational transitions in the loop cluster that disrupted a putative pathway for delivery of
substrate protons required in Q redox chemistry. Our results elucidate in detail the essential
role of accessory subunit LYRM6 for the function of eukaryotic complex I and offer clues on
its redox-linked proton pumping mechanism.
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W ith a mass of ~1MDa and more than 40 subunitsmitochondrial NADH:ubiquinone oxidoreductase(complex I) is the largest enzyme complex of the
respiratory chain1–3. Complex I is a redox-driven proton pump
that contributes ~40% of the proton motive force driving ATP
synthase. Dysfunction of respiratory complex I causes neuro-
muscular and neurodegenerative diseases4. Formation of reactive
oxygen species (ROS) by complex I contributes to tissue damage
in myocardial infarction5,6. The reversible active (A) to deactive
(D) transition is thought to protect against reperfusion injury.
Fourteen so-called central subunits of complex I are highly
conserved from bacteria to human. Supposedly, they harbor all
bioenergetic core functions of the enzyme complex. Electrons
from NADH are accepted at the tip of the hydrophilic matrix arm
and are transferred via a chain of Fe–S clusters to the ubiquinone
(Q) reduction site close to Fe–S cluster N2 (Fig. 1). This site is
connected with the membrane bilayer by a ~35 Å long tunnel for
access of the hydrophobic substrate (Fig. 1 inset). Q reduction is
coupled to proton pumping in the membrane arm of complex I,
at a maximal distance of ~200 Å, which is remarkable at mole-
cular length scales. We have proposed that a concerted rearran-
gement of three protein loops at the interface of membrane and
matrix arm plays a key role in the coupling mechanism7 and also
possibly in the trapping and release of Q8 (Fig. 1 inset). However,
despite recent progress in structure determination and functional
characterization of complex I, our understanding of redox-linked
proton translocation at the molecular level is still fragmentary.
The function of accessory subunits surrounding the core of
central subunits is largely uncharacterized. We have reported that
deletion of the gene for accessory subunit NDUFA6 caused
complete loss of Q reductase activity despite assembly of all
central subunits9, but molecular aspects of this inactivity have
remained unclear. NDUFA6 belongs to the superfamily of LYRM
proteins that typically form a heterodimer with the mitochondrial
acyl carrier protein (ACPM, NDUFAB1) and bind the acyl
cofactor, respectively10–14. Here we use the designation LYRM6
for this subunit. The LYRM6-ACPM heterodimer binds close to
the functionally critical interface region of membrane and matrix
arm of complex I (Fig. 1) and two adjacent loops of accessory
LYRM6 interact with central subunits of mitochondrial complex
I1. Here, we show by combining mutagenesis, structural biology,
and molecular dynamics (MD) simulations the presence of a
proton transfer pathway in this critical region connecting the bulk
N phase with the active site. Our data suggest an essential func-
tion of accessory subunit LYRM6 in the controlled access of
chemical protons for Q reduction in eukaryotic complex I.
Results and discussion
Site-directed mutagenesis of two loops of accessory subunit
LYRM6. In this work, we exchanged single residues in LYRM6
that contact central subunits ND3, NDUFS2, and NDUFS7 by
site-directed mutagenesis (Supplementary Figs. 1, 2, Supple-
mentary Table 1). For several mutants we observed decreased
complex I activity while assembly of the enzyme complex was
unperturbed (Supplementary Table 1, Supplementary Fig. 3). A
substantial decrease of Q reductase activity was caused by
exchange of LYRM6 residues interacting with residues in central
subunits NDUFS2 (W90ALYRM6) and NDUFS7 (Q92ALYRM6)
and accessory subunit NDUFA9 (E44ALYRM6). The strongest
impact on activity with residual rates below 25% was observed for
mutants L42ALYRM6, Y43ALYRM6, and F89ALYRM6 (Fig. 1 inset).
Interestingly, these residues reside in the center of the accessory
LYRM6 loop arrangement that interacts with a short section
(L42-T43-S44ND3) of the TMH1-2ND3 loop that is downstream to
the functionally highly critical and conserved E39-C40-G41ND3
segment (see below) (Fig. 1 inset, Supplementary Fig. 2). Residue
F89LYRM6 of the accessory LYRM6 loop forms a prominent
supporting structural element for the TMH1-2ND3 loop (Sup-
plementary Fig. 2). Analysis of purified mutant complex I by EPR
spectroscopy excluded global assembly defects and loss or
derangement of any EPR detectable Fe-S clusters (Supplementary
Fig. 4). Overall, these results demonstrate that in three indepen-
dent cases fully assembled complex I mutated in one position of
accessory subunit LYRM6 showed dramatically decreased com-
plex I activity.
Cryo-EM structure of mutant F89ALYRM6. To understand the
structural basis of this remarkable impact on eukaryotic complex
I function, we determined the structure of inactive F89ALYRM6
mutant by cryo-EM (Fig. 2, Supplementary Table 2).
Comparison of the 3.0 Å resolution map with our recent 3.2 Å
resolution structure of the WT15 showed that the matrix arm was
tilted and density corresponding to specific structural elements in
the interface region was missing indicating disorder (Fig. 2,
Supplementary Figs. 5 and 6). This included residues A37-
Q47ND3 of the TMH1-2ND3 loop, residues E208-E218ND1 of the
TMH5-6ND1 loop, residues R219-K228A9, R281-L289A9 and
D342-N359A9 of accessory NDUFA9, and several lipids at the
membrane interface (Fig. 2, Supplementary Fig. 5). Density for
the β1-β2S2 loop was visible but less clear precluding modeling of
side chain positions for H91S2, P92S2 and H95S2 (Fig. 2,
Supplementary Fig. 5d). It is remarkable that a single mutation
affecting a contact point of accessory subunit LYRM6 with the
TMH1-2ND3 loop causes structural changes in three central
subunits and over a maximal distance of more than 50 Å. This





























Fig. 1 Conserved loop cluster of mitochondrial complex I formed by
central subunits ND1, ND3, and NDUFS2. Architecture of mitochondrial
complex I from Y. lipolytica (PDB 6RFR). Cofactors of the central subunits
(FMN and Fe-S clusters) and a bound Q molecule (Q) in the access
pathway are highlighted (electron transfer pathway to Q is indicated by red
arrow). The peripheral arm is composed of the N module (NADH
oxidation) and the Q module (Q reduction). The membrane arm represents
the proton pumping (P) module with the pathways (blue arrows) for
pumped protons H+P. The reduction of Q requires electrons from terminal
Fe-S cluster N2 and two protons for Q redox chemistry (H+Q, black arrow)
from the negative side of the membrane. Interfaces between modules are
indicated by black dashed lines. The accessory LYRM6/ACPM1 (NDUFA6/
NDUFAB1-α) heterodimer at the Q/P module interface is highlighted.
Subunits ND1, ND3, and NDUFS2 form an important part of the Q/P
module interface region. Inset, the TMH1-2ND3 loop of subunit ND3
(yellow) is located at the Q/P module interface and interacts with the N-
terminal β-sheetS2 of subunit NDUFS2 (green). The TMH5-6ND1 loop (hot
pink), THM1-2ND3 loop (yellow) and β1-β2S2 loop (green) form a conserved
loop cluster. The tunnel for access of Q to the Q reduction site is shown in
transparent brown color and the Q reduction site close to Y144S2 is
highlighted in brown dashed lines. Residues L42LYRM6, Y43LYRM6,
F89LYRM6, Y144S2, the Q molecule and acyl cofactor are shown in stick
representation, respectively.
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reacts as an interconnected structural unit and supports the
proposed role of the TMH1-2ND3 loop to transmit and drive
structural changes in the interface loop cluster and active site. We
have previously shown that the unfolded Q site model for the A/
D transition developed for mammalian complex I16 does not
apply to the yeast enzyme15. Nevertheless, the changes observed
in the F89ALYRM6 mutant are comparable to the structural
differences that were previously described between the A and D
form of complex I from mouse17 (Supplementary Fig. 7). This
surprising similarity highlights the inherent flexibility of the
interface region. However, in contrast to controlled and reversible
relaxation of mouse complex I into the D form, disruption of a
stabilizing interaction between LYRM6 and the TMH1-2ND3 loop
causes an irreversible decrease of activity in the Y. lipolytica
LYRM6 mutant(s) (Supplementary Table 1).
Several lines of evidence have highlighted the critical role of the
TMH1-2ND3 loop. Upstream of the interaction site with LYRM6,
the TMH1-2ND3 loop harbors a strictly conserved EXG motif
(E39ND3-G41ND3). Mutation of invariant E39ND3 to alanine in
bacterial complex I is known to drastically affect the Q reductase
activity18. In addition, positions of human pathogenic mutations
S34PND3, S45PND3, and A47TND3 (human complex I numbering)
are close to the LYRM6/ND3 interface19 (Supplementary Fig. 8).
In mitochondrial complex I and many bacterial species the
central residue of the EXG motif is a cysteine (C40ND3).
Immobilization of the E39-C40-G41ND3 segment of the TMH1-
2ND3 loop by an engineered disulfide bond in mutant Q133CS7
(C40ND3-C133S7) was recently shown to disengage the proton
pumps20. The residue corresponding to E39ND3 in the eubacter-
ium Thermus thermophilus was also suggested to reside at the
entrance of a channel-like path for delivery of protons for Q
redox chemistry close to Fe-S cluster N221 (Supplementary
Figs. 2e and 9b). Note that conversion of Q to QH2 requires two
electrons and two substrate protons and that the timing of
coupled electron and proton transfer events is thought to be of
fundamental importance for the coupling mechanism of complex
I22–24. Uncontrolled protonation of reduced Q intermediates by
bulk protons would result in heat production instead of
controlled energy conversion for the generation of proton
pumping strokes. Therefore, concerted (re-)protonation of
anionic Q intermediates or highly conserved and functionally
essential residues H91S2, H95S2 and Y144S2 of the β1-β2S2
loop25–28 from the bulk N phase via highly conserved E39ND3
could be central to the proton pumping mechanism. Noteworthy,
the TMH1-2ND3 loop segments harboring the EXG motif were
modeled in alternative conformations in T. thermophilus and Y.
lipolytica complex I structures suggesting flexibility at this
position15,29 (Supplementary Fig. 9).
CAVER tunnel calculations and mutagenesis of tunnel resi-
dues. Our CAVER-based30,31 structural analysis of WT Y. lipo-
lytica complex I (PDB 6RFR) revealed a tunnel mainly formed by
the flexible loops of central subunits ND1, ND3, NDUFS2 and by
a helical element of NDUFS7, connecting the bulk N phase with
the middle of the Q channel (Fig. 3a, Supplementary Table 3,
Supplementary Fig. 10). Interestingly, the entrance of the tunnel
was shaped by several residues of accessory subunits LYRM6 and
NDUFA9, respectively (Supplementary Table 3). The tunnel had
a length of 60 Å and a bottleneck radius of 1.27 Å. Highly con-
served residue E39ND3 of the TMH1-2ND3 loop was part of the
tunnel and the tunnel entrance was close to the LYRM6/ND3
interface (Fig. 3a). To evaluate the functional significance of the
identified CAVER tunnel we exchanged ten residues of central
subunits NDUFS2 and NDUFS7 to alanines by site-directed
mutagenesis (Supplementary Table 3, Supplementary Fig. 10).
Eight of ten mutants of the tunnel showed decreased complex I
activity below 20% indicating functional relevance of the tunnel.
CAVER analysis using our model of the F89ALYRM6 mutant
revealed disruption of the CAVER tunnel at position of the β1-
β2S2 loop (Supplementary Fig. 10).
Multiscale modeling and simulations of WT and mutant
enzymes. In order to understand the dynamical aspects of
putative proton access pathways and why point mutations in an
accessory subunit affect Q reductase activity so drastically, we
performed fully atomistic MD simulations of WT Y. lipolytica
complex I, and F89ALYRM6 and Y43ALYRM6 mutants (Supple-
mentary Table 4). In our simulations of WT enzyme, we identi-
fied a hydrated pathway at the interface of ND1, ND3 and
NDUFS2 subunits, in similar location to the passage observed in
our CAVER-based structural analysis (Fig. 3a, b). The hydrated
channel in mitochondrial complex I involved several functionally
important residues, also from the central loop cluster and active
site of Q reduction (Fig. 3b, Supplementary Table 3), and might
be used for substrate proton transfer. Notably, some of the resi-
dues identified by CAVER analysis and also by hydration analysis
in simulations indeed show low Q reductase activity upon point
mutations (Supplementary Table 3). Interestingly, in WT simu-
lations functionally critical E39ND3 stabilized ion pairing with the
conserved K130ND1 of the ND1 subunit (Fig. 3f), an interaction
observed in two structures of mammalian complex I17,32 (Sup-
plementary Fig. 9). When we modeled a hydronium ion (H3O+)
in the hydrated channel, it rapidly transferred to the anionic
E39ND3 via Grotthuss-like proton transfer on water wires in
multiple independent QM/MM (quantum mechanical/molecular
mechanical) MD simulations of WT enzyme (Supplementary
Table 6, Supplementary Fig. 11). Protonation of E39ND3 did not
occur in F89ALYRM6 mutant simulation, whereas when E39ND3
was modeled neutral in WT setup, proton remained stable on it.
Furthermore, rapid protonation of functionally critical H91S2
from E39ND3 was found to occur in a QM/MMMD run when the
two residues are hydrogen bonding (Supplementary Fig. 11).
These simulations of explicit proton transfer support the view
that the channel could be used to supply substrate protons via the








Fig. 2 Weak or missing density in cryo-EM map indicates disorder at the
interface of membrane and matrix arm of inactive mutant F89ALYRM6.
Superimposed models of F89ALYRM6 mutant (cyan) and WT complex I
from Y. lipolytica (PDB 6RFR, gray) (superimposed at the central section of
the membrane arm (subunit ND4); Fe-S cluster N2 is shown in sphere
representation). Structural elements showing disorder in mutant
F89ALYRM6 are highlighted in red. Inset, residues at position 89LYRM6 of
subunit LYRM6 are shown in stick representation for WT and mutant.
Structural elements of subunits ND1 (hot pink), ND3 (yellow), NDUFS2
(green) and accessory NDUFA9 (forest) showing disorder in mutant
F89ALYRM6 are displayed in cartoon representation (density maps are
shown in Supplementary Fig. 5). The arrow indicates tilting of the peripheral
arm in the mutant (Supplementary Fig. 6).
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In classical MD simulations of the F89ALYRM6 mutant, the
conformation of the backbone of the L42-T43-S44ND3 segment
that brushes the ND3 loop was clearly different from that of the
WT enzyme. Due to the space created by the smaller side chain at
position 89LYRM6 in LYRM6, the TMH1-2ND3 loop segment was
found to be much more flexible and relaxed towards LYRM6, and
away from the β1-β2S2 loop (Fig. 3d, e). A similar, albeit weaker
effect, was also seen in the simulations of the Y43ALYRM6 mutant
(Supplementary Fig. 12). When F89ALYRM6 simulations were
performed with H91S2 protonated, the shift in ND3 loop segment
was observed, whereas in WT case it remained relatively stable
(Supplementary Fig. 12). The mobility and structural displacement
of the TMH1-2ND3 loop segment observed in several independent
mutant simulations is in agreement with the cryo-EM data on the
F89ALYRM6 mutant that showed the absence of density for the
ND3 segment involving residues A37-Q47ND3 (Supplementary
Fig. 5d). To compare the dynamics of the TMH1-2ND3 loop with
bacterial enzymes that lack accessory subunits, we performed
atomistic MD simulations on the complex I structure from T.
thermophilus (PDB 4HEA) and also on the large-scale model of
complex I from Y. lipolytica (PDB 6RFR, Supplementary Table 4).
The data revealed a higher level of mobility in the TMH1-2ND3
loop in bacterial complex I compared to the eukaryotic enzyme
(Supplementary Fig. 13). The observed difference in loop
dynamics most likely originates from the absence of LYRM6
accessory subunit in the bacterial enzyme even though the two
enzymes (Y. lipolytica and T. thermophilus complexes) differ in
several aspects such as subunit composition and sequence
variation. This suggests that the LYRM6 subunit not only provides
scaffolding to the functionally important TMH1-2ND3 loop, but
also restricts its dynamics to allow functionally coordinated
movements (Fig. 3). We propose that bacterial enzymes utilize the
same proton transfer pathway, but due to the lack of coordinated
movement of ND3 loop, the protonation of anionic intermediates
at the Q redox site is controlled differently.
Interestingly, the conformation of the ND3 loop segment
observed in F89ALYRM6 mutant simulations prevented stabiliza-
tion of the K130ND1-E39ND3 ion-pair (Fig. 3g) and also led to the
creation of a barrier by a short stretch of hydrophobic residues















































































































































Fig. 3 Dynamics of key segments at the interface of ND3 and LYRM6 subunits. (a) shows the Q binding cavity (beige) and the tunnel identified (light
green) in WT Y. lipolytica complex I structure (PDB 6RFR) using CAVER software31 (radius 1.27 Å). Residue E44LYRM6 highlights the entrance of the tunnel.
Hydration of the proposed proton transfer path is shown by a dark gray mesh (b) calculated by averaging water occupancy in WT simulations. In contrast,
in F89ALYRM6 mutant MD simulations, the hydrated path is blocked by conserved hydrophobic residues (L211ND1 and V212ND1) from the ND1 subunit (c)
due to structural rearrangements. The absence of the bulky side chain in the F89ALYRM6 mutant causes instability in the ND3 segment and its
displacement towards the LYRM6 segment (d), and away from the β1-β2S2 loop (e). The selected distances are shown as histograms calculated from
simulation trajectories. See also Supplementary Table 5 for similar data on complex I structures. The salt-bridge (K130ND1-E39ND3) is stabilized in WT
simulation (f) in contrast to F89ALYRM6 mutant simulations (g); gray, conformation of K130ND1 in WT structure (PDB 6RFR). Shift of the short hydrophobic
stretch from ND1 loop segment (L211-V212-A213-G214ND1) blocks the channel, as shown by time series and histogram of distance between E39ND3 and
V212ND1 (h, i). Subunit and amino acid coloring as in Fig. 1 along with selected residues shown in sticks and labeled. The isovalue of the mesh is 0.2 (20%
water occupancy) in panels (b) and (c), and two simulation replicas were used to calculate hydration (r1 and r2 in WT and r1 and r3 in mutant, see also
Supplementary Figs. 15, 16). In panels (d, e, and i), the histograms show the distribution of distances normalized so that the area under curve equals 1.
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the hydrated channel observed in WT simulations (Fig. 3c). We
note that a similar obstruction of the channel is seen in bovine
complex I33 (Supplementary Fig. 14) formed by residues L207-
V208ND1 analogous to L211-V212ND1 in Y. lipolytica complex I
(Supplementary Table 5). Exchange of the corresponding valine
residue in human complex I is a well-known pathogenic
mitochondrial mutation34 (Supplementary Fig. 8). Missing density
for the L211-V212ND1 segment in the F89ALYRM6 mutant map
precluded its structural modeling; however, simulations supported
the existence of differently populated conformational substates
(Fig. 3). Conformational flexibility, as seen in F89ALYRM6 cryo-
EM experiment, can also be interpreted as additional conforma-
tional states visited by TMH5-6ND1 and TMH1-2ND3 loops, which
are less populated in WT enzyme. In our simulations, a correlation
between V212ND1-E39ND3 distance and channel hydration was
found (Supplementary Figs. 15 and 16). A shorter V212ND1-
E39ND3 distance, as observed in F89ALYRM6 mutant simulations,
blocked the channel hydration in the region, whereas larger
V212ND1-E39ND3 distance was associated with a higher level of
hydration (Fig. 3 and Supplementary Figs. 15 and 16). We suggest
that the F89ALYRM6 induced change in conformation of the
conserved loop cluster (TMH1-2ND3, β1-β2S2 and TMH5-6ND1
loops) closes the hydrated path observed in WT simulations, and
thus prevents the transfer of substrate protons required for Q
reduction chemistry from the N phase of the membrane
(Supplementary Fig. 17). The conserved hydrophobic segment
from functionally critical TMH5-6ND1 loop (Supplementary
Table 5) may thus function as a necessary gating element for
controlled transfer of substrate protons. In contrast to the
F89ALYRM6 mutant, simulations of the uncoupled Q133CS7
mutant (with C40ND3-C133S7 disulfide bond modeled) showed
no blockage by the TMH5-6ND1 segment and formation of a
hydrated path similar to WT (Supplementary Fig. 12). The arrest of
the TMH1-2ND3 loop by the C40ND3-C133S7 disulfide bond in the
previously described Q133CS7 mutant20 would preclude closing of
the proposed substrate proton pathway. Thus, an uncontrolled
flow of protons from the bulk to the Q reduction site might explain
uncoupling of redox chemistry from proton pumping in the
Q133CS7 mutant by decreasing the lifetime of negatively charged
reaction intermediates28.
Taken together, we demonstrate that a single point mutation in
the accessory LYRM6 subunit has a significant impact on the
energy conversion reactions of mitochondrial complex I. Our
high-resolution structure of mutant F89ALYRM6 and MD
simulations show that structural perturbations originating at a
contact point of LYRM6 with the TMH1-2ND3 loop propagate to
functionally critical loops of central subunits at the interface of
membrane and matrix arm. This indicates that amino acid
residues from the accessory subunit provide indispensable
stabilizing interactions for the efficient functioning of mitochon-
drial complex I. Our combined structural and simulation data
suggests the presence of an entry pathway for protons consumed
in Q redox chemistry, and that the control of proton access to the
active site is critical for the coupling mechanism of complex I.
While this paper was under revision, two high-resolution cryo-
EM structures of mitochondrial complex I were published35,36.
Based on conserved positions of water molecules, Grba and
Hirst35 suggested a pathway for substrate proton transfer in the
peripheral arm close to the Q reduction site of complex I.
Kampjut and Sazanov36 on the other hand suggested the uptake
of chemical protons from the bulk N phase into core hydrophobic
subunit ND4L of the membrane arm. The two proposed
pathways for chemical protons are strikingly different from our
findings as our combined biochemical, structural, and computa-
tional data indicate that the central loop cluster is the structural
element that provides proton access to the active site in a
controlled fashion. Further work is needed to unravel the
functional significance of each proposed proton transfer pathway.
Methods
Site-directed mutagenesis of complex I subunits from Y. lipolytica. Point
mutations were generated by inverse PCR mutagenesis using the plasmids pUB26-
WT-nb4m(lyrm6), pUB26-WT-nucm and pUB4-WT-nukm. After sequencing, the
plasmids were transformed into Y. lipolytica strain Δnb4m/lyrm6, Δnucm or
Δnukm9,26. Plasmid DNA was transformed into Y. lipolytica cells using the lithium
acetate method. Cells from 0.5–1ml of an overnight culture were spun down, washed
with 0.9% NaCl and centrifuged again. The cells were re-suspended in 90 µl of 50%
PEG4000 in the presence of 100mM lithium acetate pH 6, 100mM DTT and 0.25
mg/ml ssDNA. 200–300 ng of plasmid DNA were added for each transformation
mixture, vortexed and incubated at 39 °C for 60min. After transformation, the cells
were plated on the appropriate selection medium and incubated for 3–4 days at 28 °C.
Preparation of mitochondrial membranes and purification of complex I. Y.
lipolytica WT (GB30) strain and the strains complemented with the plasmid car-
rying the WT genes were grown in YPD medium with or without hygromycin,
respectively. Mitochondrial membranes were prepared as described previously26.
For small scale preparation of mitochondrial membranes, pellets of 5–8 g of cells
(wet weight) in 50 ml falcon tubes were re-suspended in 10 ml mito-buffer (600
mM sucrose, 20 mM Mops, 1 mM EDTA, pH 7.2) supplemented with 2 mM
PMSF. Cells were broken by vortexing in a series of 15 × 1 min with 1 min resting
intervals on ice in the presence of 10 g glass beads (0.25–0.5 mm). The resulting
suspension was filtered through gauze and filled up to 30 ml with the mito-buffer.
Cells debris and glass beads were removed by centrifugation at 3238 × g (4000 rpm,
Megafuge, rotor 2704) for 30 min at 4 °C. Supernatants were collected and mito-
chondrial membranes were sedimented by ultracentrifugation at 147,642 × g
(35,000 rpm, rotor Ti 50.2) for 1 h at 4 °C. Finally, the supernatant was discarded,
and pellets were re-suspended in 0.5–1 ml mito-buffer. The suspension was then
homogenized on ice in the presence of 5 mM PMSF using a glass homogenizer.
Aliquots of the membrane suspension were immediately frozen in liquid nitrogen
and stored at −80 °C. For purification of complex I, large-scale preparations of
mitochondrial membranes were performed. Up to 200 g of cells (wet weight) of Y.
lipolytica harvested after fermentation were re-suspended in 400 ml mito-buffer.
Cells were broken using a cooled Cell-Desintegrator-C (Bernd Euler Biotechno-
logie) and 80 ml of 0.5 mm glass beads for 2 h. Cells debris was removed by
centrifugation with 4416 × g (5000 rpm; rotor JA10) for 30 min at 4 °C. The
supernatant was filtered through gauze and diluted with the mito-buffer up to a
final volume of 450 ml. Mitochondrial membranes were obtained by ultra-
centrifugation with 167,425 × g (38,000 rpm, rotor Ti 45) for 1.5 h at 4 °C. Pelleted
membranes were re-suspended in mito-buffer without EDTA and centrifuged
174,040 × g (38,000 rpm, rotor Ti 50.2) for 1 h at 4 °C. Pelleted membranes were
homogenized and the membrane suspension was supplemented with 20 mM Na-
borate pH 7.9, 50 mM NaCl and 1.5 mM PMSF. Aliquots were frozen in liquid
nitrogen immediately after preparation and stored at −80 °C.
Complex I was solubilized with n-dodecyl-ß-D-maltoside (DDM) as detailed in37;
however, purification buffers contained 0.025% 2,2-didecylpropane-1,3-bis-β-D-
maltopyranoside (LMNG) instead of DDM. Mitochondrial membranes were thawed
and diluted to a concentration of 18mg/ml protein with 50mM NaCl, 20mM Na-
borate; pH 7.9, 1.5mM PMSF. DDM was added dropwise with stirring on ice to a
final detergent to protein ratio of 1g:1g. The solution was further stirred on ice for 10
min and then centrifuged at 147,642 × g (35,000 rpm; rotor Ti50.2) for 1 h at 4 °C.
The supernatant was adjusted to 400mM NaCl, 55mM imidazole, 0.8mM MgCl2
and pH 7.3–7.4 and loaded onto a Ni-NTA sepharose column (Bio-Rad), which was
prior equilibrated with buffer A (55mM imidazole, 400mM NaCl, 0.025% LMNG,
and 20mM Na-phosphate, pH 7.2). The presence of the 6xHis tag attached to the
30 kDa subunit of the peripheral arm of complex I allows the enzyme to bind. After
washing the column with 150ml of the same buffer (buffer A), complex I was eluted
with buffer B (200ml of 140mM imidazole, 400mM NaCl, 0.025% LMNG, and
20mM Na-phosphate, pH 7.2) containing a higher imidazole concentration.
Fractions with a HAR activity (see below) higher than 20 U/ml were combined and
concentrated using Centriped centrifugal filter devices (Millipore®). To remove
imidazole and to optimize purity of the complex I sample, the concentrated pool was
applied to a TSK G4000SW column (TosoH Bioscience) and separated by size
exclusion chromatography on an ÄKTA purifier chromatography system (GE
Healthcare). Equilibration and elution were performed with FPLC buffer (100mM
NaCl, 1mM EDTA, 20mM Tris/HCl, pH 7.2 and 0.025% LMNG). The process was
monitored by UV absorption at 280 nm characteristic for protein and 415 nm
characteristic for the FMN, which is a cofactor of complex I. Peak fractions were
pooled and concentrated using spin devices (Vivaspin, 100,000 MWCO, Sartorius).
Aliquots were shock frozen and stored in liquid nitrogen.
Specific NADH:hexaammineruthenium(III) (HAR) and 2-decyl-4-
quinazolinylamine (DQA) inhibitor-sensitive deamino-NADH:decyl-ubiquinone
(dNADH:DBQ) oxidoreductase activity were measured for mitochondrial
membranes. NADH:HAR and NADH:DBQ activities of purified enzymes were
measured in the presence of 0.01% LMNG. Complex I content in mitochondrial
membranes as well as in purified enzyme is typically determined as NADH:HAR
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oxidoreductase activity. This unphysiological reaction depends on the presence of
an intact NADH oxidation site in the N-module of complex I and reflects the
amount of fully assembled complex I in a preparation. The reaction was monitored
spectrophotometrically at 340 nm wavelength (ε= 6.22 mM−1 cm−1) for a decrease
in absorbance proportional to NADH oxidation. The reaction was started by the
addition of 20–40 µg protein of mitochondrial membranes or 1–2.5 µg of purified
complex I to the HAR buffer (250mM sucrose, 20 mM HEPES, 0.2 mM EDTA,
2mM KCN, ±0.01% LMNG; pH 8) containing 200 µM NADH and 2mM HAR.
Activity measurements were performed at 30 °C in a Shimadzu UV-2450
spectrophotometer and all values were normalized to the protein concentration. For
each mutant two biological replicates were analyzed, and each measurement was
carried out in duplicate. Complex I activities in mitochondrial membranes as well as
in purified enzyme were determined by measuring the physiological electron
transfer activity of NADH to ubiquinone. Short chain ubiquinone analogues were
used to avoid solubility problems due to the isoprene chain of Q9, which is the
natural electron acceptor of complex I from Y. lipolytica. To exclude NADH
oxidation by alternative dehydrogenase (NDH2) in mitochondria of Y. lipolytica,
deaminoNADH (dNADH) instead of NADH was used during the activity assays.
dNADH is a NADH analogue in which the adenine moiety is replaced by
hypoxanthine. The reaction was started by the addition of 100 µM dNADH/NADH
to a solution of DBQ buffer (20mM MOPS-Na; 50mM NaCl; 2 mM KCN, ±0.01%
LMNG; pH 7.2) containing 60/150 µM DBQ and 20–40 µg protein of mitochondrial
membranes or 2–5 µg of purified complex I. The reaction was stopped by the
addition of 2 µM complex I inhibitor 2-decyl-4-quinazolinylamine (DQA). The
inhibitor-insensitive activity was subtracted from the initial measurement and the
result was normalized to complex I content to allow comparison between different
preparations. All activities measurements were performed at 30 °C in a Shimadzu
UV-2450 spectrophotometer. For each mutant two biological replicates of
mitochondrial membranes were analyzed, and each measurement was carried out in
duplicate. Source data are provided as a Source Data file.
Electrophoresis. Mitochondrial membranes from Y. lipolytica were solubilized by
DDM and separated by blue native electrophoresis (BN-PAGE) with an 4–16%
acrylamide gradient38. Briefly, mitochondrial membranes (400 µg protein) were
first diluted in 300 µl of water and sedimented by centrifugation for 10 min at
16,100 × g. The membrane pellets were re-suspended with 40 µl solubilization
buffer A (50 mM imidazole/HCl; 50 mM NaCl; 2 mM 6-aminohexanoic acid;
1 mM EDTA; pH 7.0). 1.5 g DDM per g protein was added to the sample and left to
solubilize for 10 min on ice. The solubilized membranes were centrifuged at 16,100
× g for 45 min at 4 °C and supernatants were supplemented with 5% Coomassie
brilliant blue G-250 and 5 µl of 50% glycerol. 20 µl samples were then loaded on
4–16% acrylamide gradient gels (Bio-Rad) and protein complexes were separated
for about 4 h at 16 mA and 400 V in the cold room (4 °C). Uncropped gel is
provided as a Source Data file.
EPR Spectroscopy. X-band EPR spectra were obtained with a Bruker ESP 300E
spectrometer equipped with an HP 53159A frequency counter (Hewlett Packard),
ER 035M NMR gaussmeter (Bruker, BioSpin), and a liquid helium continuous flow
cryostat (Oxford Instruments). Spectra were recorded using the following para-
meters: microwave frequency 9.47 GHz, microwave power 1 mW, modulation
amplitude 0.64 mT, and modulation frequency 100 kHz. Samples were reduced
with 2 mM NADH. For comparison spectra were normalized on signal intensities
of gxN3 and gxN4. Spectra were recorded at 12 K to analyze binuclear and tetra-
nuclear clusters. Samples were frozen in cold isopentane/methylcyclohexane (5:1,
120 K) and stored in liquid nitrogen.
Structure modeling and CAVER analysis. For structural modeling we employed
the bioinformatic tool PyMOL39 using the pdb entry files PDB 6RFR (WT Y.
lipolytica15), PDB 6G2J (mouse A form17), PDB 6H8K (Q133CS7 Y. lipolytica20),
PDB 5LNK (sheep complex I14), PDB 6QC5 (sheep closed form32), PDB 6QBX
(sheep closed form32), PDB 4HEA (T. thermophilus29), PDB 5LC5 (bovine complex
I33), PDB 5XTH (human complex I40), PDB 5XTD (human complex I40), PDB
6HUM (photosynthetic complex I41) and PDB 6CFW (membrane bound hydro-
genase, MBH42). CAVER 3.031 was used as PyMOL39 plugin. The critical Y144S2
near cluster N2 served as initial starting point for tunnel calculation. The input
model comprised the central subunits ND1, ND3, NDUFS2, NDUFS7 and the
accessory subunits LYRM6 (NDUFA6), ACPM1 (NDUFAB1) and NDUFA9 from
Y. lipolytica complex I. The minimum probe radius (bottleneck radius) varied from
1.2 Å to 1.5 Å and correspond to the narrowest part of a given tunnel. All other
parameters maintained default.
Cryo-EM structure. Complex I F89ALYRM6 mutant was purified in LMNG as
detergent and polished by ion exchange chromatography using a MonoQ column.
The sample was applied at a concentration of 1.5mg/ml to freshly glow-discharged
1.2/1.3 holey carbon grids (Protochips). Grids were automatically blotted for 12–14 s
in a Vitrobot Mark IV (Thermo Fisher Scientific Inc., USA) at 10 °C and 70%
humidity (drain and wait time 0 s, blot force −2 a.u. (arbitrary units)), plunge-frozen
in liquid ethane and stored in liquid nitrogen until further use. Cryo-EM data were
collected automatically using EPU software (Thermo Fisher Scientific Inc.) on FEI
Titan Krios microscope (Thermo Fisher Scientific Inc.) at 300 kV equipped with K3
Summit detector (Gatan) operating in counting mode. Cryo-EM images were
acquired at a nominal magnification of 105,000x with a calibrated pixel size of
0.837 Å, a defocus range from −1.5 to −2.5 μm, an exposure time of 3 s, and a total
electron exposure on the specimen of ~51.8 e−/Å2. A set of 2016 dose-fractionated
micrographs were subjected to motion correction and dose-weighting of frames by
MotionCor243. The micrograph-based contrast transfer function (CTF) was deter-
mined by Gctf and the resulting images were used for further analysis with the
software package RELION3.044. Particles were picked using Autopick within
RELION3.0 and a total of 479,372 particles were extracted with a box size of 400 ×
400 pixels. The extracted particles were subjected to reference-free 2D classification,
which was performed with four-fold binned data to remove false positives and
imperfect particles. A further 3D classification with a previous cryo-EM map of WT
Y. lipolytica complex I15 as an initial reference was applied. The best 3D class of
143,203 particles was used for auto-refinement, CTF refinement and Bayesian pol-
ishing in RELION3.044. The final map at 2.96 Å resolution was sharpened using an
isotropic B-factor of –65 Å2 and the local resolution was estimated with ResMap
(http://resmap.sourceforge.net)45 (Supplementary Fig. 5). All resolutions were esti-
mated using the 0.143 cutoff criterion46 with gold-standard Fourier shell correlation
(FSC) between two independently refined half maps47. The cryo-EM structure of WT
Y. lipolytica complex I (PDB 6RFR) was used as template and critical areas were
rebuilt with COOT48. The structure was refined using phenix.real_space_refine in
combination with rigid-body refinement49. A quality check indicated excellent ste-
reochemistry with 94.0% of the non-glycine and non-proline residues found in the
most-favored regions and 0.06% outliers (all-atom clashscore: 8.07). Refinement and
validation statistics are summarized in Supplementary Table 2.
Atomistic molecular dynamics simulations. We performed atomistic classical
molecular dynamics (MD) simulations of complex I from Y. lipolytica (PDB 6RFR)
(see also50). We did not use the F89ALYRM6 mutant structure because of the missing
density in the ND3/LYRM6 region, which would preclude unambiguous modeling
of protein backbone and sidechains. The MD model systems included core subunits
NDUFS2, NDUFS7, NDUFS3, NDUFS8, ND1, ND3, ND6, ND4L, ND2, and ND5
(terminal helix), as well as accessory subunits LYRM6 (NDUFA6), NDUFAB1,
NDUFA12, NDUFA5, and NDUFA9. The selected subunits and cofactors fully
encompass the region of interest (Fig. 3a), and smaller model systems were found
stable (see below). In test simulations, we observed some of the N and C terminals
of protein chains to be highly flexible (residue 1–54 NDUFS7, 36–52 and 256–272 in
NDUFS3, 128–137 in NDUFA12, 40–65 in NDUFS8). Therefore, these were
removed in order to maintain the small size of the simulation box. The structurally
resolved quinone (Q9) molecule was included in the simulations. Standard proto-
nation states of all amino acids were used, except H95S2, which was kept protonated
in all the simulations (see also Supplementary Table 4 for H91S2 protonation states).
The protein system was embedded into a pure POPC lipid membrane obtained
from CHARMM-GUI51–56 and aligned by OPM alignment57. The membrane-
protein system was solvated with TIP3 water molecules and 0.1M of Na+ and Cl−
ions. CHARMM force field was used for all components of the simulation setup;
protein, lipids, solvent58–60, iron-sulfur clusters61, ZMP53, and quinone62. The total
system size was ca. 452,000 atoms (see Supplementary Fig. 18). The entire protein-
membrane-solvent system was energy minimized followed by two equilibration
steps in which constant temperature (310 K) and pressure (1 atm) were achieved
with Berendsen thermostat63 and Parrinello-Rahman barostat64,65, respectively. In
the first equilibration step (100 ps NVT and 1 ns NPT), 2000 kJ mol−1 nm−2 con-
straints were applied on the heavy atoms of the protein but keeping the ligands free.
In the second step, all constraints were released, and an energy minimization
procedure was followed by a 100 ps NVT and 1 ns NPT equilibration MD run.
During production simulations, the temperature and pressure were kept at 310 K
and 1 atm, respectively, using Nose-Hoover thermostat (time constant 1 ps)66,67 and
Parrinello-Rahman barostat (time constant 5 ps)64,65. The time step of the simu-
lation was 2 fs, which was achieved by using the LINCS algorithm68 and long-range
electrostatics (12 Å cutoff) was dealt with Particle-mesh Ewald method69 imple-
mented in GROMACS (with van der Waals cutoff 12 Å).
To shed light on the stability of protein models simulated and to compare our
results with bacterial enzyme that lacks accessory subunits, we also performed
atomistic MD simulations on full structures of respiratory complexes from Y.
lipolytica (PDB 6RFR) and T. thermophilus (PDB 4HEA) (see setups 7–9 in
Supplementary Table 4). For modeling setup of large-scale models, see15,70. We
find despite removing core/accessory subunits in WT and mutant models (setups
1–6), the systems remained stable as shown by root mean square displacement
(Supplementary Fig. 18) and secondary structure analysis (Supplementary Fig. 19).
All MD simulations were performed with simulation software GROMACS
(versions 2018.6 and 2020.2)71–73. The simulation trajectories were analyzed with
software VMD (1.9.3–1.9.5)74, PyMOL (2.3)39 and CAVER (3.0)30,31,75.
Quantum mechanical/Molecular mechanical (QM/MM) simulations. We
performed hybrid QM/MM MD simulations on selected classical MD snapshots to
study the proton transfer reactions in the identified proton transfer pathway. We used
QCHEM and CHARMM software51,76, B3LYP density functional77–80 with 6–31 G*
basis set as implemented in QCHEM for QM/MM simulations, which were based on
additive electrostatic embedding framework. The classical (MM) region comprised
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hydrated ND6, ND3, NDUFA9, LYRM6, ND1, NDUFS7, and NDUFS2 subunits,
whereas the QM region consisted of selected amino acid residues, water molecules,
and hydronium ion. The model systems and simulation lengths are described in
Supplementary Table 6. The boundary between QM and MM regions was treated by
link atoms introduced between Cα and Cβ atoms of selected amino acid residues.
Initially, classical energy minimization was performed on the whole system for
1000 steps. This was followed by a 200 step QM/MM energy minimization, prior to
the start of QM/MM MD runs. The QM/MM MD simulations were performed at
310 K with 1 fs time step and dispersion corrections81.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The cryo-EM structures of complex I mutant F89ALYRM6 has been deposited in the PDB
with PDB ID 6Y79 (Cryo-EM structure of a respiratory complex I F89A mutant) and the
respective cryo-EM maps in the EMDB under accession numbers EMD-10711 (Cryo-EM
structure of a respiratory complex I F89A mutant). All data needed to evaluate the
conclusions in the paper are present in the paper and/or the Supplementary Information.
Additional data related to this paper may be requested from the authors. Source data are
provided with this paper.
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